This is a preview of subscription content, log in via an institution to check access.
Reference
Fried I, et al. Utilization, Cost, and Outcome of Branded vs Compounded 17-Alpha Hydroxyprogesterone Caproate in Prevention of Preterm Birth. JAMA Internal Medicine : 2 Oct 2017. Available from: URL: http://dx.doi.org/10.1001/jamainternmed.2017.5017
Rights and permissions
About this article
Cite this article
Value of branded 17-α hydroxyprogesterone caproate?. PharmacoEcon Outcomes News 789, 32 (2017). https://doi.org/10.1007/s40274-017-4439-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4439-0